Forte Biosciences Surges on $2.2 Billion Cash Buyout Deal

By: Quiver PriceTracker

Posted: 1 month, 2 weeks ago / July 27, 2026 2:53 p.m. UTC

FBRX

Forte Biosciences (FBRX) is up 39.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The sharp move appears to be driven primarily by argenx’s agreement to acquire Forte Biosciences for $77 per share in cash, a takeout price that closely matches the stock’s jump. Investor enthusiasm was likely reinforced by Forte’s recent positive FB102 clinical data, which helped support the strategic value of the deal.

Details:

argenx and Forte Biosciences announced a definitive merger agreement under which argenx will launch a cash tender offer for all outstanding Forte shares at $77 per share.

The transaction values Forte Biosciences at about $2.2 billion, giving the market a clear benchmark for where the shares could trade after the announcement.

Forte recently reported positive Phase 1b vitiligo results for FB102, and the buyer highlighted that anti-CD122 antibody as an important addition to its immunology pipeline.

Earlier in 2026, argenx had already made a strategic investment in Forte, which suggests the acquisition followed a period of growing conviction rather than a sudden change in interest.

Sources:

Forte Biosciences, argenx, SEC

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive FBRX Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$FBRX Hedge Fund Activity

We have seen 37 institutional investors add shares of $FBRX stock to their portfolio, and 21 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

MPM BIOIMPACT LLC added 1,000,682 shares (+inf%) to their portfolio in Q1 2026, for an estimated $25,917,663
ADAGE CAPITAL PARTNERS GP, L.L.C. added 616,667 shares (+185.0%) to their portfolio in Q1 2026, for an estimated $15,971,675
POINT72 ASSET MANAGEMENT, L.P. removed 487,275 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $12,620,422
MORGAN STANLEY added 429,767 shares (+609.3%) to their portfolio in Q1 2026, for an estimated $11,130,965
CITADEL ADVISORS LLC added 233,369 shares (+inf%) to their portfolio in Q1 2026, for an estimated $6,044,257
FRED ALGER MANAGEMENT, LLC removed 187,006 shares (-12.8%) from their portfolio in Q1 2026, for an estimated $4,843,455
JAIN GLOBAL LLC removed 186,836 shares (-92.3%) from their portfolio in Q1 2026, for an estimated $4,839,052

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.